Type 1 Diabetes

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP   Modern management of type 1 diabetes comprises a package of measures including multiple daily injections for a more physiological insulin replacement; assessment of glycaemic control using blood glucose self-monitoring as well as clinic tests such as glycated haemoglobin (HbA1c); insulin dosage …

The device, only tested in mice, also can release insulin to prevent acidosis…. 

A peptide called caerulein can convert existing cells in the pancreas into insulin-generating beta cells….

Initial findings suggest relationship but with sibling-control analyses, effect almost disappears….

Beta cell encapsulation therapy is a procedure that involves implantation of cells with the ability to secrete insulin in a glucose-responsive manner in a protective barrier into the body…. On July 17th 2014, the Juvenile Diabetes Research Foundation (JDRF) announced that their partner, ViaCyte, Inc. filed an Investigational New Drug …

The best outcomes were achieved by multiple daily injections with self-monitoring of blood glucose…. 

A new delivery system has been evaluated and found to be safe and effective for young adults to use at home without any supervision needed….

A peptide called caerulein converted existing cells in the pancreas into insulin-generating beta cells….

  Rudy Bilous MD, FRCP Richard Donnelly MD, PHD, FRCP, FRACP   The most common cause of type 1 diabetes (over 90% of cases) is T cell-mediated autoimmune destruction of the islet beta cells leading to a failure of insulin production. The exact aetiology is complex and still imperfectly understood. However, it …

Low-carbohydrate diets should be the first line of attack for treatment of type 2 diabetes, and should be used in conjunction with insulin in those with type 1 diabetes…. Conducted by a consortium of 26 physicians and nutrition researchers, the study suggests the need for a reappraisal of dietary guidelines due to the …